A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer. – Cost Effective Supplements

A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer.

Quick navigation

Link
Conclusion
Supplements
Functions
Systems

Link to full study

http://www.ncbi.nlm.nih.gov/pubmed/22689129

Conclusion of this study

POMx treatment was associated with ≥ 6 month increases in PSADT in both treatment arms without adverse effects. The significance of this on-study slowing of PSADT remains unclear, reinforcing the need for placebo-controlled studies in this patient population.